2022
Optimizing the Design and Analysis of Future AKI Trials
Legrand M, Bagshaw SM, Koyner JL, Schulman IH, Mathis MR, Bernholz J, Coca S, Gallagher M, Gaudry S, Liu KD, Mehta RL, Pirracchio R, Ryan A, Steubl D, Stockbridge N, Erlandsson F, Turan A, Wilson FP, Zarbock A, Bokoch MP, Casey JD, Rossignol P, Harhay MO. Optimizing the Design and Analysis of Future AKI Trials. Journal Of The American Society Of Nephrology 2022, 33: 1459-1470. PMID: 35831022, PMCID: PMC9342638, DOI: 10.1681/asn.2021121605.Peer-Reviewed Original ResearchConceptsAKI trialsClinical trialsTrial participantsTrial designAKI clinical trialsPerioperative patient populationsComplex clinical syndromeRisk of morbidityPragmatic trial designTreatment effectsClinical trial planningImportant treatment effectsClinical trial analysisAKI preventionClinical courseClinical syndromePatient populationTrial interventionClinical questionsClinical trialistsAKITrial infrastructureTrial planningTrialsEfficient enrollmentAngiopoietins as Prognostic Markers for Future Kidney Disease and Heart Failure Events after Acute Kidney Injury
Mansour SG, Bhatraju PK, Coca SG, Obeid W, Wilson FP, Stanaway IB, Jia Y, Thiessen-Philbrook H, Go AS, Ikizler TA, Siew ED, Chinchilli VM, Hsu CY, Garg AX, Reeves WB, Liu KD, Kimmel PL, Kaufman JS, Wurfel MM, Himmelfarb J, Parikh SM, Parikh CR. Angiopoietins as Prognostic Markers for Future Kidney Disease and Heart Failure Events after Acute Kidney Injury. Journal Of The American Society Of Nephrology 2022, 33: 613-627. PMID: 35017169, PMCID: PMC8975075, DOI: 10.1681/asn.2021060757.Peer-Reviewed Original ResearchConceptsCKD progressionHeart failureLower riskAngpt-1Highest quartileFuture kidney diseaseSetting of AKIAcute kidney injuryHeart failure admissionsHeart failure eventsProspective cohort studyMortality 3 monthsPlasma angiopoietinsKidney injuryCohort studySecondary outcomesEndothelial injuryMedian agePrimary outcomeKidney diseasePrognostic markerAngiopoietin-2AKIAngiopoietin-1Vessel destabilization
2021
A Comparison Study of Coronavirus Disease 2019 Outcomes in Hospitalized Kidney Transplant Recipients.
Mansour SG, Malhotra D, Simonov M, Yamamoto Y, Arora T, Subair L, Alausa J, Moledina DG, Greenberg JH, Wilson FP, Marin EP. A Comparison Study of Coronavirus Disease 2019 Outcomes in Hospitalized Kidney Transplant Recipients. Kidney360 2021, 2: 494-506. PMID: 35369023, PMCID: PMC8786009, DOI: 10.34067/kid.0005652020.Peer-Reviewed Original ResearchConceptsKidney transplant recipientsHospital complicationsVasopressor useSARS-CoV-2Baseline eGFRTransplant recipientsElixhauser scoreBlack raceSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Coronavirus disease 2019 (COVID-19) outcomesRespiratory syndrome coronavirus 2High ferritin levelsSyndrome coronavirus 2High rateElectronic health recordsFerritin levelsComparator groupCoronavirus 2Higher oddsViral infectionLarger sample sizeHigh mortalityComplicationsAKI
2020
A Time-Updated, Parsimonious Model to Predict AKI in Hospitalized Children
Sandokji I, Yamamoto Y, Biswas A, Arora T, Ugwuowo U, Simonov M, Saran I, Martin M, Testani JM, Mansour S, Moledina DG, Greenberg JH, Wilson FP. A Time-Updated, Parsimonious Model to Predict AKI in Hospitalized Children. Journal Of The American Society Of Nephrology 2020, 31: 1348-1357. PMID: 32381598, PMCID: PMC7269342, DOI: 10.1681/asn.2019070745.Peer-Reviewed Original ResearchConceptsExternal validation cohortValidation cohortElectronic health recordsSevere AKIClinical risk stratification toolDevelopment of AKIHealth recordsRisk stratification toolInternal validation cohortLength of stayCharacteristic curveElectronic medical recordsNeonatal AKIInpatient mortalitySecondary outcomesHospital admissionPrimary outcomeHospitalized childrenCreatinine valuesMedical recordsStudy populationAKICohortChildrenPredictive variables
2019
Community Health Care Quality Standards to Prevent Acute Kidney Injury and Its Consequences
Silver SA, Nadim MK, O'Donoghue DJ, Wilson FP, Kellum JA, Mehta RL, Ronco C, Kashani K, Rosner MH, Haase M, Lewington A. Community Health Care Quality Standards to Prevent Acute Kidney Injury and Its Consequences. The American Journal Of Medicine 2019, 133: 552-560.e3. PMID: 31830434, PMCID: PMC7724764, DOI: 10.1016/j.amjmed.2019.10.038.Peer-Reviewed Original ResearchConceptsAcute Disease Quality InitiativePrevent Acute Kidney InjuryCommunity health care providersAcute kidney injuryHealth care continuumHealth care providersQuality improvement initiativesKidney injurySerum creatinineUnnecessary medicationsBlood pressureRisk stratificationUrine dipstickCare continuumPatient educationCare providersInjury increasesPrevention strategiesCare processesHealth responseAKIHealth systemCare measurementDelphi processImprovement initiatives
2018
Acute Kidney Injury in Real Time: Prediction, Alerts, and Clinical Decision Support
Wilson FP, Greenberg JH. Acute Kidney Injury in Real Time: Prediction, Alerts, and Clinical Decision Support. Nephron 2018, 140: 116-119. PMID: 30071528, PMCID: PMC6165685, DOI: 10.1159/000492064.Commentaries, Editorials and LettersConceptsPresence of AKIAcute kidney injury (AKI) researchShort-term adverse outcomesBest practice advisoryDetection of AKIEHR-based toolsAcute kidney injuryChronic kidney diseaseKidney injurySerum creatinineClinical decision supportAdverse outcomesElectronic health record systemsKidney diseaseAdministrative codingHarmful sequelaeHealth record systemsAKIInjury researchProvider behaviorRecord systemSequelaeCreatinineInjuryDiseaseUtility of Electronic Medical Record Alerts to Prevent Drug Nephrotoxicity
Martin M, Wilson FP. Utility of Electronic Medical Record Alerts to Prevent Drug Nephrotoxicity. Clinical Journal Of The American Society Of Nephrology 2018, 14: 115-123. PMID: 29622668, PMCID: PMC6364537, DOI: 10.2215/cjn.13841217.Commentaries, Editorials and LettersConceptsElectronic medical record alertsAppropriate drug dosingRisk of AKIAKI alertsDrug nephrotoxicityInappropriate prescribingPrompt recognitionClinical outcomesIatrogenic formDrug dosingPatient benefitAKIPrescribers' actionsOff-target effectsPatientsSuch alertsMethods of evaluationNephrotoxicityPrescribingDosingNephrotoxinsBiomarkers of AKI Progression after Pediatric Cardiac Surgery
Greenberg JH, Zappitelli M, Jia Y, Thiessen-Philbrook HR, de Fontnouvelle CA, Wilson FP, Coca S, Devarajan P, Parikh CR. Biomarkers of AKI Progression after Pediatric Cardiac Surgery. Journal Of The American Society Of Nephrology 2018, 29: 1549-1556. PMID: 29472416, PMCID: PMC5967766, DOI: 10.1681/asn.2017090989.Peer-Reviewed Original ResearchConceptsAKI progressionOptimism-corrected areaIL-8First dayStage 3 AKIUrine L-FABPProspective cohort studyBiomarkers of inflammationPediatric cardiac surgeryConfidence intervalsAKI stagePostoperative AKIKidney injuryCohort studySerum creatinineCardiac surgeryCardiopulmonary bypassTherapeutic trialsUrine biomarkersAdverse outcomesHospitalized childrenPlasma biomarkersClinical careAdditional cohortAKI
2013
Sundays and Mortality in Patients with AKI
Wilson FP, Yang W, Schrauben S, Machado C, Lin JJ, Feldman HI. Sundays and Mortality in Patients with AKI. Clinical Journal Of The American Society Of Nephrology 2013, 8: 1863-1869. PMID: 23970128, PMCID: PMC3817908, DOI: 10.2215/cjn.03540413.Peer-Reviewed Original Research